News
- Author:
- Sue Hughes
Publish date: November 8, 2023
The ABIM’s maintenance of certification process has been widely criticized for many years and has been described as “needlessly burdensome and expe...
News
- Author:
- Sue Hughes
Publish date: November 7, 2023
In medicine at large, there is a stereotype that cardiologists can be “arrogant, unkind, and unwelcoming,” which may discourage new fellows from ho...
News
- Author:
- Sue Hughes
Publish date: October 31, 2023
“We require randomized trials with longer follow-up prior to abandoning this potential treatment.”
News
- Author:
- Sue Hughes
Publish date: October 30, 2023
“Cardiovascular mortality occurred at a rate of about 1% per year with both therapies, strokes at the rate of 1% per year with both therapies, and ...
News
- Author:
- Sue Hughes
Publish date: October 25, 2023
The findings may not only explain the link between COVID and the increased risk of cardiovascular events but mark a starting point for new therapeu...
News
- Author:
- Sue Hughes
Publish date: October 17, 2023
“Risk scores derived when risk variables were described in one way are starting to be applied based on a diagnosis made in a totally different way....
News
- Author:
- Sue Hughes
Publish date: October 12, 2023
Recommendations to reduce the global burden of stroke include measures to improve surveillance, prevention, acute care, and rehabilitation.
News
- Author:
- Sue Hughes
Publish date: September 29, 2023
The efficacy data in the phase 3 trials will be key to the success of these drugs. “That is a very important part of the puzzle that is still missi...
News
- Author:
- Sue Hughes
Publish date: September 20, 2023
“ZALEA-TIMI 71 represents a landmark study confirming the promise of Factor XI inhibition as causing substantially less bleeding than a current sta...
News
- Author:
- Sue Hughes
Publish date: September 14, 2023
“I think the most important take-home message here is that the use of these medications appears to be safe even in really acutely ill hospitalized ...
News
- Author:
- Sue Hughes
Publish date: September 12, 2023
“After the initial triage and management decisions, then most of the rest of the care follows a common pathway so it would make sense to consider e...
News
- Author:
- Sue Hughes
Publish date: September 7, 2023
Interleukin-1 receptor antagonist anakinra appeared safe but did not reduce complications of acute myocarditis in the ARAMIS trial.<...
News
- Author:
- Sue Hughes
Publish date: September 6, 2023
“While these absolute event rates are extremely low, they are unquestionably higher in the nonaspirin group.”
News
- Author:
- Sue Hughes
Publish date: August 30, 2023
“Currently, aside from intravenous hydration, there is no proven treatment that reduces contrast-induced nephropathy. We feel that dietary inorgani...
News
- Author:
- Sue Hughes
Publish date: August 28, 2023
It was hoped that the study would confirm benefits suggested in previous smaller studies, but its modest results seem to have caused more uncertain...
